(Q35907804)

English

Sustained remission of symptoms and improved health-related quality of life in patients with cryopyrin-associated periodic syndrome treated with canakinumab: results of a double-blind placebo-controlled randomized withdrawal study

scientific article published on 9 December 2011

Statements

Sustained remission of symptoms and improved health-related quality of life in patients with cryopyrin-associated periodic syndrome treated with canakinumab: results of a double-blind placebo-controlled randomized withdrawal study (English)
Jasmin B Kuemmerle-Deschner
Kieron S Leslie
Alberto Ferreira
Karine Lheritier
Philip N Hawkins
Canakinumab in CAPS Study Group

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit